Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Rhode

Showing results (21-30 of 43) with videos related to

Pageof 5
Sort By:
Cytokine|February 18, 2018
Evaluation of the biological activities of the IL-15 superagonist complex, ALT-803, following intravenous versus subcutaneous administration in murine modelsBai Liu, Monica Jones, Lin Kong, et al.
Protein Engineering, Design & Selection : PEDS|December 24, 2010
Interleukin-15:Interleukin-15 receptor α scaffold for creation of multivalent targeted immune moleculesRichard L Wong, Bai Liu, Xiaoyun Zhu, et al.
Tribology Letters|September 17, 2025
Linear Reciprocating Tribometer for In Situ Neutron Reflectometry of Soft MatterKathryn E Shaffer, Brendan Louie Bagorio, Ahmed Al Kindi, et al.
Plos One|June 5, 2014
Intravesical ALT-803 and BCG treatment reduces tumor burden in a carcinogen induced bladder cancer rat model; a role for cytokine production and NK cell expansionEvan Gomes-Giacoia, Makito Miyake, Steve Goodison, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 14, 2011
Phase I trial of ALT-801, an interleukin-2/T-cell receptor fusion protein targeting p53 (aa264-272)/HLA-A*0201 complex, in patients with advanced malignanciesMayer N Fishman, John A Thompson, Gregory K Pennock, et al.
Cytokine|October 25, 2011
IL-15:IL-15 receptor alpha superagonist complex: high-level co-expression in recombinant mammalian cells, purification and characterizationKai-ping Han, Xiaoyun Zhu, Bai Liu, et al.
Human Vaccines & Immunotherapeutics|July 27, 2012
Assessing the interest to participate in a dengue vaccine efficacy trial among residents of Puerto RicoCarmen L Pérez-Guerra, Rosa L Rodríguez-Acosta, Eunice Soto-Gómez, et al.
Cancer Research|May 7, 2013
Efficacy and mechanism-of-action of a novel superagonist interleukin-15: interleukin-15 receptor αSu/Fc fusion complex in syngeneic murine models of multiple myelomaWenxin Xu, Monica Jones, Bai Liu, et al.
Plos One|May 29, 2014
Development, calibration and performance of an HIV transmission model incorporating natural history and behavioral patterns: application in South AfricaAlethea W McCormick, Nadia N Abuelezam, Erin R Rhode, et al.
The Journal of Biological Chemistry|September 22, 2016
A Novel Fusion of ALT-803 (Interleukin (IL)-15 Superagonist) with an Antibody Demonstrates Antigen-specific Antitumor ResponsesBai Liu, Lin Kong, Kaiping Han, et al.
Pageof 5

Showing results (21-30 of 43) with videos related to

Sort By:
Pageof 5
Cytokine|February 18, 2018
Evaluation of the biological activities of the IL-15 superagonist complex, ALT-803, following intravenous versus subcutaneous administration in murine modelsBai Liu, Monica Jones, Lin Kong, et al.
Protein Engineering, Design & Selection : PEDS|December 24, 2010
Interleukin-15:Interleukin-15 receptor α scaffold for creation of multivalent targeted immune moleculesRichard L Wong, Bai Liu, Xiaoyun Zhu, et al.
Tribology Letters|September 17, 2025
Linear Reciprocating Tribometer for In Situ Neutron Reflectometry of Soft MatterKathryn E Shaffer, Brendan Louie Bagorio, Ahmed Al Kindi, et al.
Plos One|June 5, 2014
Intravesical ALT-803 and BCG treatment reduces tumor burden in a carcinogen induced bladder cancer rat model; a role for cytokine production and NK cell expansionEvan Gomes-Giacoia, Makito Miyake, Steve Goodison, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 14, 2011
Phase I trial of ALT-801, an interleukin-2/T-cell receptor fusion protein targeting p53 (aa264-272)/HLA-A*0201 complex, in patients with advanced malignanciesMayer N Fishman, John A Thompson, Gregory K Pennock, et al.
Cytokine|October 25, 2011
IL-15:IL-15 receptor alpha superagonist complex: high-level co-expression in recombinant mammalian cells, purification and characterizationKai-ping Han, Xiaoyun Zhu, Bai Liu, et al.
Human Vaccines & Immunotherapeutics|July 27, 2012
Assessing the interest to participate in a dengue vaccine efficacy trial among residents of Puerto RicoCarmen L Pérez-Guerra, Rosa L Rodríguez-Acosta, Eunice Soto-Gómez, et al.
Cancer Research|May 7, 2013
Efficacy and mechanism-of-action of a novel superagonist interleukin-15: interleukin-15 receptor αSu/Fc fusion complex in syngeneic murine models of multiple myelomaWenxin Xu, Monica Jones, Bai Liu, et al.
Plos One|May 29, 2014
Development, calibration and performance of an HIV transmission model incorporating natural history and behavioral patterns: application in South AfricaAlethea W McCormick, Nadia N Abuelezam, Erin R Rhode, et al.
The Journal of Biological Chemistry|September 22, 2016
A Novel Fusion of ALT-803 (Interleukin (IL)-15 Superagonist) with an Antibody Demonstrates Antigen-specific Antitumor ResponsesBai Liu, Lin Kong, Kaiping Han, et al.
Pageof 5